ISMPP Highlights
13th Annual Meeting of ISMPP – A Great Success!
The 13th Annual Meeting of ISMPP was a great success, with its programming focused on the meeting theme, Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data Sharing. Over 560 attendees participated in the meeting, held May 1-3, 2017, at the Gaylord National Resort and Convention Center, in National Harbor, Maryland, USA…
Advocacy & Outreach Committee Focuses on Strategic Targets
One aspect of ISMPP’s mission is to advance the medical publication profession globally through education, advocacy, and professional collaborations. ISMPP fulfills this mission in various ways, with the Advocacy & Outreach (A&O) Committee serving a key role. The current A&O Committee is focusing its effort on three strategic targets…
Eighth International Congress on Peer Review and Scientific Publication
The aim of the Eighth International Congress on Peer Review and Scientific Publication is to encourage research into the quality and credibility of peer review and scientific publication, to establish the evidence base on which scientists can improve the conduct, reporting, and dissemination of scientific research…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Preparing Manuscript Submissions: Plan to Submit Supporting Documentation!
Rigorous journal peer review ensures the quality of manuscripts and, ultimately, the credibility of the published literature. Peer reviewers should have access to documentation relating to the research they are reviewing. In an era of so-called fake news, predatory publishing, and scrutiny of industry activities…
A New Age of Transparency: Do We Fully Understand the Implications?
Over the last few years, requirements for clinical trial transparency and data reporting have become more extensive to help patients and health care practitioners (HCPs) better understand the drugs they are taking or prescribing in clinical trials, with a focus on increasing trust and confidence in regulatory decisions on medicines. Publication professionals within sponsor companies must…
ICMJE Releases Highly Anticipated Data Sharing Requirements
The International Committee of Medical Journal Editors (ICMJE), which is comprised of various member journals including the New England Journal of Medicine (NEJM) and The Lancet, just published its highly anticipated data sharing requirements on June 6, 2017. These new requirements are subsequent to the ICMJE’s initial clinical trial data sharing proposal published in January 2016…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Delayed Review Calls Authorship into Question
You are a company medical publication professional. The lead author of a manuscript in development was key in acquiring data for the study and actively engaged in the initial discussions that shaped the outline for the paper. However, he/she was slow to send feedback…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals